lean-body-mass decline
Secure Muscle Gains: Semaglutide Beats Tirzepatide
In a routine-care study, athletes on tirzepatide lost up to 5% more lean mass than those on semaglutide, indicating a clear muscle-preserving advantage for the latter. This difference can affect power output, recovery speed, and long-term performance during aggressive weight-loss programs. Medical Disclaimer: This article is for informational purposes only